17 results
8-K
EX-99.1
LTRN
Lantern Pharma Inc
9 Aug 23
Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights
4:05pm
, 2023.
“We made significant strides over the past quarter in executing our mission of transforming the oncology drug discovery and development process
8-K
EX-99.1
LTRN
Lantern Pharma Inc
9 May 23
Lantern Pharma Reports First Quarter 2023 Financial Results and Operational Highlights
4:05pm
for the first quarter ended March 31, 2023.
“This quarter we continued to execute our mission of transforming the oncology drug discovery and development
DEF 14A
2iw7g6j82j22myt
9 Apr 21
Definitive proxy
11:30am
10-K
513 idag8n83bab
10 Mar 21
Annual report
4:07pm
424B4
0en4g0k
15 Jan 21
Prospectus supplement with pricing info
5:24pm
DRS
pnfgnz7kbo
16 Dec 20
Draft registration statement
12:00am
424B4
s6nd daasw6
12 Jun 20
Prospectus supplement with pricing info
7:49am
S-1
g8n3d4eiuml4gzrny0gz
16 Apr 20
IPO registration
3:32pm
DRS
4zv3k36m
24 Jan 20
Draft registration statement
12:00am
- Prev
- 1
- Next